NAC for Attenuation of COVID-19 Symptomatology

Clinical trial NCT05074121 · UNKNOWN

Trial details

NCT number: NCT05074121
Sponsor: Cambridge Health Alliance
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Covid19 COVID-19 Pneumonia COVID-19 Respiratory Infection COVID-19 Lower Respiratory Infection SARS-CoV2 Infection SARS-CoV-2 Acute Respiratory Disease SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere Oxidative Stress

Start date: 2024-03-31
Primary completion: 2024-12-31
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.